Alethia Malaria 480925
Ref 480925
Alethia Malaria 480925 is a multiple Plasmodium species nucleic acid IVD (EU IVDR Class C; FDA Class II; FDA product code OAX, Plasmodium Spp. Detection Reagents) made by Meridian Bioscience Inc., registered in EUDAMED on 15 Sep 2026 (Basic UDI-DI 008407331ALETHIACLC008RR) and listed in FDA GUDID since 26 Oct 2020 (UDI-DI 00840733102240), active as of 8 Nov 2026.
Active
CE IVDR
Valid until
No date given
FDA recalls
Not checked
Documents
None linked in EUDAMED
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/IVDR EUDAMED | Number008407331ALETHIACLC008RR 00840733102240 | Date15 Sep 2026 | StatusActive |
| United States | GUDID listing GUDID | Number00840733102240 | Date26 Oct 2020 | StatusListed |
Official records
- EUDAMED public site 008407331ALETHIACLC008RR
- AccessGUDID record 00840733102240
From the FDA record
- Device description
- The Alethia Malaria amplification assay, performed on the Alethia Incubator/Reader, is a qualitative in vitro diagnostic test for the direct detection of Plasmodium sp. DNA in human venous EDTA whole blood specimens from individuals with signs and symptoms of malarial infection. Results from Alethia Malaria assays are intended to be used as an aid in the diagnosis of human malaria infection. Alethia Malaria assay utilizes loop-mediated isothermal DNA amplification (LAMP) technology to detect Plasmodium sp. DNA by targeting segments of the Plasmodium genome. Alethia Malaria assay does not distinguish between Plasmodium species. Alethia Malaria is intended for use in hospital, reference or state laboratory settings. The device is not intended for nonlaboratory point-of-care use.
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- EUDAMED Basic UDI-DI 008407331ALETHIACLC008RR registered 15 Sep 2026 Active
- FDA GUDID UDI-DI 00840733102240 listed 26 Oct 2020 Listed
Timeline
- Listed FDA GUDID 00840733102240
- Registered EUDAMED 008407331ALETHIACLC008RR
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- Trade name
- alethia® Malaria EUDAMEDAlethia Malaria GUDID
- Generic name
- Multiple Plasmodium species nucleic acid IVD, kit, nucleic acid technique (NAT)
- Model / Ref / Catalog
- 480925
- Primary DI / UDI-DI
- 00840733102240
- Basic UDI-DI
- 008407331ALETHIACLC008RR
- Direct marketing DI
- 00840733102240
- FDA product code
- OAX
- EMDN code
- W0105050209 Plasmodium (malaria)
- GMDN term
- Multiple Plasmodium species nucleic acid IVD, kit, nucleic acid technique (NAT)
- Device class
- Class C EUDAMEDClass II GUDID
- Regulation number
- 866.3402
- EU registration type
- Standard device
- EU market of registration
- Italy
- GUDID distribution status
- In Commercial Distribution
Truth per registry
| Field | EUDAMED | GUDID |
|---|---|---|
| Device class | Class C | Class II |
Similar devices in this category
Other devices filed under PLASMODIUM (MALARIA).
- Trinity Biotech 2322471 by CLARK LABORATORIES, INC.
- Bio-Rad 72526 by CLARK LABORATORIES, INC.
- Real-time PCR Detection Kit for Plasmodium Malariae ID046 by Beijing Applied Biological Technologies Co., Ltd.
- Captia™ Malaria EIA 2322470 / 2322471 by Trinity Biotech USA
- Plasmodium Falciparum/Plasmodium Vivax Antigen Rapid Test Cassette (Colloidal Gold Method) IH012 by Beijing Applied Biological Technologies Co., Ltd.
- miLab™ Cartridge MAL CMAA by Noul Co., Ltd.
- Malaria P.f./P.v. Rapid Test Cassette IMPV-402 by Hangzhou Alltest Biotech.Co.,Ltd.
- Malaria pf/pv Antigen Rapid Test Kit (Colloidal gold method) CR002 by Nanjing Synthgene Medical Technology Co., Ltd.
- Malaria P.f/Pan Antigen Combo Rapid Test Kit G11817 by Beijing Diagreat Biotechnologies Co., Ltd.
- Malaria P.f./Pan Rapid Test Cassette IMPN-402 by Hangzhou Alltest Biotech.Co.,Ltd.